Clinical trials
Non-alcoholic Fatty Liver Disease trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 11 |
| 2018 | 8 |
| 2019 | 14 |
| 2020 | 11 |
| 2021 | 15 |
| 2022 | 10 |
| 2023 | 16 |
| 2024 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| German Institute of Human Nutrition | 5 |
| Institute of Liver and Biliary Sciences, India | 5 |
| National Nutrition and Food Technology Institute | 4 |
| Assiut University | 3 |
| Charite University, Berlin, Germany | 3 |
| Maastricht University Medical Center | 3 |
| Ziv Hospital | 3 |
| Hospital de Clinicas de Porto Alegre | 2 |
| Hvidovre University Hospital | 2 |
| Maastricht University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 128 |
| Obesity | 30 |
| Fatty Liver | 16 |
| Metabolic Syndrome | 13 |
| Diabetes Mellitus, Type 2 | 11 |
| Overweight | 7 |
| Dyslipidemias | 6 |
| Inflammation | 6 |
| Insulin Resistance | 6 |
| Liver Cirrhosis | 6 |
Trials
Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.